Journal
CURRENT ONCOLOGY REPORTS
Volume 11, Issue 1, Pages 68-72Publisher
SPRINGER
DOI: 10.1007/s11912-009-0011-9
Keywords
-
Categories
Funding
- National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]
- Collaborative Ependymoma Research Network (CERN)
- American Lebanese Syrian Associated Charities (ALSAC)
- NATIONAL CANCER INSTITUTE [R01CA129541, P30CA021765, P01CA096832] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Recent history has witnessed unparalleled advances in our understanding of tumor biology, owing in large part to the publication of the human genome project. Paired with improvements in microarray technologies, the combination of genetic and expression profiles provides a unique opportunity to further enhance our understanding of the underlying mechanisms that drive tumor growth. Thus, integrated analysis of identified molecular changes with clinical and histologic data may further delineate a new risk stratification system for pediatric brain tumors, allowing more patient-tailored therapy and molecular-based therapeutic interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available